These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 1324256

  • 1. Treatment of HIV infection: the antiretroviral nucleoside analogues. Introduction.
    McLeod GX, Hammer SM.
    Hosp Pract (Off Ed); 1992 Aug; 27 Suppl 2():3-4. PubMed ID: 1324256
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy of HIV infection with nucleoside analogs].
    Jablonowski H, Mauss S, Armbrecht C, Manegold C, Szelenyi H, Hengels KJ.
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():60-6. PubMed ID: 8197806
    [No Abstract] [Full Text] [Related]

  • 4. Therapy for human immunodeficiency virus infection -- what have we learned?
    Corey L, Holmes KK.
    N Engl J Med; 1996 Oct 10; 335(15):1142-4. PubMed ID: 8813046
    [No Abstract] [Full Text] [Related]

  • 5. An approach to antiretroviral treatment of HIV disease. Nucleoside monotherapy.
    Gunnarsson G, Hammer SM.
    Hosp Pract (1995); 1995 Aug 10; 30 Suppl 1():5-22. PubMed ID: 7635917
    [Abstract] [Full Text] [Related]

  • 6. Managing HIV disease after Delta.
    Pinching AJ.
    BMJ; 1996 Mar 02; 312(7030):521-2. PubMed ID: 8595267
    [No Abstract] [Full Text] [Related]

  • 7. New developments in antiretroviral drug therapy for HIV-1 infections.
    Johnson VA.
    AIDS Clin Rev; 1996 Mar 02; ():305-46. PubMed ID: 7488558
    [No Abstract] [Full Text] [Related]

  • 8. [Anti-retroviral monotherapy with nucleoside analogues].
    de Mendonça JS.
    Rev Soc Bras Med Trop; 1995 Mar 02; 28 Suppl 2():5-9. PubMed ID: 8693151
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: combination therapy.
    McLeod GX, Hammer SM.
    Hosp Pract (Off Ed); 1992 Aug 02; 27 Suppl 2():14-25. PubMed ID: 1324254
    [Abstract] [Full Text] [Related]

  • 10. Antiretroviral therapy of human immunodeficiency virus type-1 (HIV-1) infection.
    Emery S, Cooper DA.
    Aust N Z J Med; 1995 Aug 02; 25(4):344-9. PubMed ID: 8540876
    [No Abstract] [Full Text] [Related]

  • 11. Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Research on AIDS.
    Saravolatz LD, Winslow DL, Collins G, Hodges JS, Pettinelli C, Stein DS, Markowitz N, Reves R, Loveless MO, Crane L, Thompson M, Abrams D.
    N Engl J Med; 1996 Oct 10; 335(15):1099-106. PubMed ID: 8813040
    [Abstract] [Full Text] [Related]

  • 12. [Anti-HIV therapy (1987-1994): from nothing to confusion].
    Lissen E.
    Med Clin (Barc); 1995 Apr 01; 104(12):463-7. PubMed ID: 7739285
    [No Abstract] [Full Text] [Related]

  • 13. A comparison of zidovudine, didanosine, zalcitabine and no antiretroviral therapy in patients with advanced HIV disease.
    Torres RA, Barr MR, McIntyre KI, Thornton JR, Shay WM, Feldman RD, George NJ, Britton DJ.
    Int J STD AIDS; 1995 Apr 01; 6(1):19-26. PubMed ID: 7727578
    [Abstract] [Full Text] [Related]

  • 14. [Antiretroviral treatment against HIV].
    González-Lahoz J, Soriano V.
    Med Clin (Barc); 1995 Sep 30; 105(10):377-8. PubMed ID: 7475441
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: monotherapy.
    Skowron G.
    Hosp Pract (Off Ed); 1992 Aug 30; 27 Suppl 2():5-13. PubMed ID: 1324257
    [Abstract] [Full Text] [Related]

  • 16. Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1.
    Commun Dis Rep CDR Wkly; 1995 Oct 20; 5(42):209. PubMed ID: 7496435
    [No Abstract] [Full Text] [Related]

  • 17. Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative Group.
    Schooley RT, Ramirez-Ronda C, Lange JM, Cooper DA, Lavelle J, Lefkowitz L, Moore M, Larder BA, St Clair M, Mulder JW, McKinnis R, Pennington KN, Harrigan PR, Kinghorn I, Steel H, Rooney JF.
    J Infect Dis; 1996 Jun 20; 173(6):1354-66. PubMed ID: 8648207
    [Abstract] [Full Text] [Related]

  • 18. AZT combination trial shows positive results.
    Nature; 1995 Sep 28; 377(6547):277. PubMed ID: 7566074
    [No Abstract] [Full Text] [Related]

  • 19. Combination superior to zidovudine in Delta trial.
    Choo V.
    Lancet; 1995 Sep 30; 346(8979):895. PubMed ID: 7564678
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.